SDGR — Schrodinger, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1490978 ·
Last close
$18.77
Market Cap
$1.23B
52W High
$20.48
52W Low
$13.05
ADV30
1,076,988
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 58,889,000 | 32,432,000 | -41,547,000 | 5,975,000 | 640,394,000 | 287,853,000 | 311,438,000 |
| Mar 2026 | 58,587,000 | 29,547,000 | -48,794,000 | -60,026,000 | 634,187,000 | 260,255,000 | 320,639,000 |
| Dec 2025 | 87,235,000 | 57,293,000 | -17,157,000 | 32,511,000 | 726,160,000 | 230,517,000 | 362,107,000 |
| Sep 2025 | 54,324,000 | 28,039,000 | -45,947,000 | -32,795,000 | 653,660,000 | 172,120,000 | 332,308,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-126,870,000
Investing CF
$186,083,000
Financing CF
$1,723,000
CapEx
$-3,401,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.77
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-682,857,000
Inventory
—
Receivables
$41,124,000
ST Investments
$125,886,000
EBIT TTM
$-153,445,000
Pretax Income TTM
$-51,931,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$259,035,008
EBITDA
$-147,579,008
Free Cash Flow
$-29,163,124
Enterprise Value
$1,168,682,880
Total Cash
$413,739,008
Total Debt
$108,003,000
Shares Out
65,641,435
Trailing EPS
$-0.73
Book Value
$4.51
ROE
-16.2%
ROA
-14.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 255,869,000 | -166,896,000 | -103,265,000 | 726,160,000 | 362,107,000 | — | 13,899,000 |
| Dec 2024 | 207,539,000 | -209,296,000 | -187,123,000 | 823,226,000 | 401,781,000 | — | -157,368,000 |
| Dec 2023 | 216,666,000 | -177,448,000 | 40,720,000 | 802,955,000 | 254,397,000 | — | -136,733,000 |
| Dec 2022 | 180,955,000 | -146,817,000 | -149,186,000 | 688,587,000 | 240,682,000 | — | -119,683,000 |
TTM Snapshot
Revenues TTM
$144,689,000
NetIncome TTM
$-175,020,000
OpCashFlow TTM
$0
Assets (Latest)
$823,226,000
Forward EPS
$-1.35
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $18.77 · call volume: 442 · put volume: 182
Expected Move to 2026-09-18:
±$2.38
(12.68%) —
implied range
$16.39 –
$21.15
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | $1.26B | $8.43 | — |
| EVOTF | Evotec SE | $1.19B | $6.69 | — |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.19B | $14.09 | — |
| SPTX | Seaport Therapeutics, Inc. | $1.29B | $24.08 | — |
| MLTX | MoonLake Immunotherapeutics | $1.31B | $15.37 | — |
News headlines (Yahoo Finance, 1h cache)
Schrodinger Q2 Earnings Call Highlights
2026-08-06 05:03 · Yahoo
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
2026-08-06 00:35 · Yahoo
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
2026-08-17 13:56 · Yahoo
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-08-14 12:30 · Yahoo
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
2026-08-11 18:00 · Yahoo
Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift – Has The Bull Case Changed?
2026-08-06 06:09 · Yahoo
Schrodinger Inc (SDGR) (Q2 2026) Earnings Call Highlights: ACV Surges 27% on Bunsen Launch and ...
2026-08-06 05:08 · Yahoo
Schrödinger Reports Second Quarter 2026 Financial Results
2026-08-05 20:05 · Yahoo
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
2026-08-05 12:30 · Yahoo
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
2026-07-27 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.